Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention (Study P03573)
Status:
Completed
Trial end date:
2007-01-28
Target enrollment:
Participant gender:
Summary
The object of the study is to determine whether different doses of SCH 530348, when added to
standard medical care in persons undergoing percutaneous coronary intervention, will increase
the risk of bleeding.
A secondary objective is to determine whether patients treated with SCH 530348 have fewer
cardiac events such as heart attack, bypass surgery, or death compared with those persons
treated with the standard of care.